Ocular’s Dry Eye Drug Fails In Phase II, But It Isn’t Giving Up Yet

 
• By Joseph Haas
Blood shot eyes
Ocular Therapeutics is working on two intracanicular inserts for dry eye disease

More from Clinical Trials

More from R&D